SMYD3 and breast carcinoma: Chromatin immunoprecipitation assays performed in breast cancer cells have shown direct association of the histone methyltransferase SMYD3 with the SHCBP1 promoter, facilitating transcriptional induction through H3K4me3 modification [30].